À©ÅÙ¹½ÃÛ¤ÎÀ¯¼£·ÐºÑ³Ø¡Ý´üÂԼ¸½¼Ò²ñ¤Ë¸þ¤±¤Æ¡Ý
English
GLOPEII¤Ë¤Ä¤¤¤Æ News ¥¤¥Ù¥ó¥È¥¹¥±¥¸¥å¡¼¥ë ¥ï¡¼¥­¥ó¥°¥Ú¡¼¥Ñ¡¼ GLOPE II À¤ÏÀÄ´ºº°ìÍ÷ ¥ê¥ó¥¯

ͽÄêɽ -¾ÜºÙ¾ðÊó-

·ï̾ BS ʬ²Ê²ñ
³«»ÏÆü»þ 2012ǯ 11·î 27Æü (²ÐÍËÆü)   10»þ40ʬ (GMT+09:00)
½ªÎ»Æü»þ 2012ǯ 11·î 27Æü (²ÐÍËÆü)   12»þ10ʬ (GMT+09:00)
¾ì½ê ²¼µ­»²¾È¤Î»ö
¾ÜºÙ ¡Ú¥°¥ë¡¼¥×1¡Û¼Â¸³¡¦À¤ÏÀÄ´ºº¡¦Åý·×ʬÀÏ
¾ì½ê¡§6¹æ´Û313-2¶µ¼¼
ÆâÍÆ¡§¡Ö¼Â¸³¼Â»Ü¤Ë¸þ¤±¤¿Ï䷹礤¤ò¹Ô¤¦¡×

¡Ú¥°¥ë¡¼¥×2¡Û»ý³²Äǽ¤ÊÀ©ÅÙÀ߷פȵ¬ÈÏŪɾ²Á
¾ì½ê¡§6¹æ´Û313¶µ¼¼
ÆâÍÆ¡§ ¡Ö²¬ÌîȬÂåÀèÀ¸¡ÊƱ»Ö¼ÒÂç³Ø¡Ë¤Ë¤è¤ë¹ÖµÁ¡ÖÆüËÜ·³¡Ö°Ö°ÂÉØ¡×ÌäÂê¤ÈÀ¯¼£³Ø¤Îº£¡×¡×

¡Ú¥°¥ë¡¼¥×3¡Û¡§¹ñºÝÀ¯¼£·ÐºÑ¥â¥Ç¥ëʬÀÏ¡¢
¾ì½ê¡§1¹æ´Û401¶µ¼¼
ÆâÍÆ¡§ ¸¦µæ¥»¥ß¥Ê¡¼
Êó¹ð¼Ô¡§ÈÓÄÍÉÒ¹¸»á¡ÊÅìµþÂç³Ø¡Ë
Êó¹ð¥¿¥¤¥È¥ë¡§Physician Agency and Adoption of Generic Pharmaceuticals
³µÍס§
I examine physician agency in health care services in the context of the choice between brand-name and generic pharmaceuticals. I examine micro-panel data from Japan, where physicians can legally make profits by prescribing and dispensing drugs. The results indicate that physicians often fail to internalize patient costs, explaining why cheaper generics are infrequently adopted. Doctors respond to markup differentials between the two versions, indicating another agency problem.¡¡However, generics¡Ç markup advantages are shortlived, which limits their impact on increasing generic adoption. Additionally, state dependence and heterogeneous doctor preferences affected generics¡Ç adoption. Policy makers can target these factors to improve static efficiency.

¡Ú¥°¥ë¡¼¥×4¡Û¡§À©ÅÙ¤ÎÀ¸À®¤ÈÀ߷פοôÍýŪ´ðÁÃÉÕ¤±
¾ì½ê¡§9¹æ´Û318¶µ¼¼
ÆâÍÆ¡§¡Ê¹ÖµÁ¡ËÀ¯¼£·ÐºÑ³Ø¤Ø¤Î¥²¡¼¥àÏÀŪ¥¢¥×¥í¡¼¥Á
¥«¥Æ¥´¥ê¡¼ À¯¼£·ÐºÑ³Ø´ðÁÃ¥»¥ß¥Ê¡¼¡¦¥é¥ó¥Á¥¿¥¤¥à¥»¥ß¥Ê¡¼
¥µ¥¤¥È¥Þ¥Ã¥×
Home¤Ø